Optimising treatment as prevention strategies for hepatitis C and HIV [ 2015 - 2017 ]

Research Grant

Researchers: Prof Mark Stoove (Principal investigator)

Brief description New evidence shows how hepatitis C (HCV) and HIV transmission can be reduced dramatically through timely treatment initiation - treatment as prevention (TasP). TasP has re-focused attention on early HCV and HIV detection and treatment. Through observational studies, randomised control trials and the development of innovative surveillance systems, this fellowship will inform ways to maximise the potential of HCV and HIV prevention responses in Australia and internationally in this new TasP era.

Funding Amount $AUD 455,452.00

Funding Scheme Career Development Fellowships

Notes Population Health CDF